Human hypoxanthine- (guanine) phosphoribosyl transferase-2
    2.
    发明授权
    Human hypoxanthine- (guanine) phosphoribosyl transferase-2 失效
    人类次黄嘌呤(鸟嘌呤)磷酸核糖转移酶-2

    公开(公告)号:US06653446B2

    公开(公告)日:2003-11-25

    申请号:US09189833

    申请日:1998-11-12

    IPC分类号: C07K100

    CPC分类号: C12N9/1077 A61K38/00

    摘要: A human HPRT-2 polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for the treatment of nephrolithiasis, anemia, precocious gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria. Antagonists against such polypeptides and their use as a therapeutic to treat disorders associated with excessive purine synthesis are also disclosed. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention are also disclosed.

    摘要翻译: 公开了编码这种多肽的人HPRT-2多肽和DNA(RNA),以及通过重组技术产生这种多肽的方法。 还公开了利用这种多肽治疗肾结石,贫血,早熟性痛风,肾结石,莱斯 - 尼汉综合征,肾衰竭和尿酸尿的方法。 还公开了抗这些多肽的拮抗剂及其作为治疗用于治疗与过量嘌呤合成相关的疾病的用途。 还公开了用于鉴定编码本发明多肽的核酸序列中突变和用于检测本发明多肽的改变水平的诊断测定。

    Soluble Interleukin-1 Receptor Accessory Molecule
    3.
    发明申请
    Soluble Interleukin-1 Receptor Accessory Molecule 审中-公开
    可溶性白细胞介素-1受体配体分子

    公开(公告)号:US20080261252A1

    公开(公告)日:2008-10-23

    申请号:US12136927

    申请日:2008-06-11

    IPC分类号: G01N33/53 C07K16/18 C12N5/06

    CPC分类号: C07H21/04 C07K14/7155

    摘要: The present invention relates to a novel soluble IL-1 receptor accessory molecule (IL-1R AcM) protein which is a member of the Ig superfamily. In particular, isolated nucleic acid molecules are provided encoding the human IL-1R AcM protein. IL-1R AcM polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. Screening methods are further provided for identifying agonist and antagonists of IL-1 signal transduction. The invention further relates to methods for treating physiologic and pathologic disease conditions with IL-1R AcM antagonists.

    摘要翻译: 本发明涉及作为Ig超家族成员的新型可溶性IL-1受体辅助分子(IL-1RACM)蛋白质。 特别地,提供编码人IL-1R AcM蛋白的分离的核酸分子。 还提供IL-1R AcM多肽,载体,宿主细胞和用于制备它们的重组方法。 还提供筛选方法用于鉴定IL-1信号转导的激动剂和拮抗剂。 本发明还涉及用IL-1R AcM拮抗剂治疗生理和病理疾病状况的方法。

    Soluble interleukin-1 receptor accessory molecule
    5.
    发明授权
    Soluble interleukin-1 receptor accessory molecule 失效
    可溶性白细胞介素-1受体辅助分子

    公开(公告)号:US06974682B1

    公开(公告)日:2005-12-13

    申请号:US08917710

    申请日:1997-08-26

    CPC分类号: C07H21/04 C07K14/7155

    摘要: The present invention relates to a novel soluble IL-1 receptor accessory molecule (IL-1R AcM) protein which is a member of the Ig superfamily. In particular, isolated nucleic acid molecules are provided encoding the human IL-1R AcM protein IL-1R AcM polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. Screening methods are further provided for identifying agonist and antagonists of IL-1 signal transduction. The invention further relates to methods for treating physiologic and pathologic disease conditions with IL-1R AcM antagonists.

    摘要翻译: 本发明涉及作为Ig超家族成员的新型可溶性IL-1受体辅助分子(IL-1RACM)蛋白质。 特别地,提供编码人IL-1R AcM蛋白的分离的核酸分子IL-1R也提供了如用于制备它们的载体,宿主细胞和重组方法的AcM多肽。 还提供筛选方法用于鉴定IL-1信号转导的激动剂和拮抗剂。 本发明还涉及用IL-1R AcM拮抗剂治疗生理和病理疾病状况的方法。

    Soluble interleukin-1 receptor accessory molecule
    9.
    发明授权
    Soluble interleukin-1 receptor accessory molecule 失效
    可溶性白细胞介素-1受体辅助分子

    公开(公告)号:US07390880B2

    公开(公告)日:2008-06-24

    申请号:US11066006

    申请日:2005-02-25

    IPC分类号: C07K14/00 C07K14/52

    CPC分类号: C07H21/04 C07K14/7155

    摘要: The present invention relates to a novel soluble IL-1 receptor accessory molecule (IL-1R AcM) protein which is a member of the Ig superfamily. In particular, isolated nucleic acid molecules are provided encoding the human IL-1R AcM protein. IL-1R AcM polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. Screening methods are futher provided for identifying agonist and antagonists of IL-1 signal transduction. The invention further relates to methods for treating physiologic and pathologic disease conditions with IL-1R AcM antagonists.

    摘要翻译: 本发明涉及作为Ig超家族成员的新型可溶性IL-1受体辅助分子(IL-1RACM)蛋白质。 特别地,提供编码人IL-1R AcM蛋白的分离的核酸分子。 还提供IL-1R AcM多肽,载体,宿主细胞和用于制备它们的重组方法。 提供筛选方法用于鉴定IL-1信号转导的激动剂和拮抗剂。 本发明还涉及用IL-1R AcM拮抗剂治疗生理和病理疾病状况的方法。